Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026

Go back to Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026
(NYSE: LCTX) Delayed: 1.26 +0.05 (4.13%)
Previous Close $1.21    52 Week High
Open $1.24    52 Week Low
Day High $1.28    P/E N/A 
Day Low $1.22    EPS
Volume 1,514,939       

(NYSE: LCTX) Delayed: 1.26 +0.05 (4.13%)
Previous Close $1.21    52 Week High
Open $1.24    52 Week Low
Day High $1.28    P/E N/A 
Day Low $1.22    EPS
Volume 1,514,939